An Update on Twenty Years of Anemia Management with Erythropoiesis-Stimulating Agents in Nephrology and Oncology/Hematology

被引：7
|
作者：
Aapro, Matti [1 ]
机构：
[1] Multidisciplinary Oncol Inst, Genolier, Switzerland
来源：
ONCOLOGIST | 2009年 / 14卷
关键词：
Anemia; Erythropoiesis stimulating agents; Erythropoietin; Nephrology; Oncology; Hematology; QUALITY-OF-LIFE; EPOETIN-ALPHA; CANCER-PATIENTS; HEMOGLOBIN LEVEL; EORTC GUIDELINES; INTRAVENOUS IRON; DOUBLE-BLIND; CHEMOTHERAPY; RECEPTOR; PROLIFERATION;
D O I：
10.1634/theoncologist.2009-S1-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [41] Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia
    Pashos, Chris L.
    Larholt, Kay
    Fraser, Kimberly A.
    McKenzie, R. Scott
    Senbetta, Mekre
    Piech, Catherine Tak
    SUPPORTIVE CARE IN CANCER, 2012, 20 (01) : 159 - 165
  • [42] Impact of Safety Concerns and Regulatory Changes on the Usage of Erythropoiesis-Stimulating Agents and RBC Transfusions
    Vadhan-Raj, Saroj
    Zhou, Xiao
    Sizer, Kurt
    Lal, Lincy
    Wang, Xuemei
    Roquemore, Joyce
    Shi, Weiming
    Benjamin, Robert S.
    Lichtiger, Benjamin
    ONCOLOGIST, 2010, 15 (12) : 1359 - 1369
  • [43] The Use of Erythropoiesis-Stimulating Agents in the Intensive Care Unit
    Piagnerelli, Michael
    Vincent, Jean-Louis
    CRITICAL CARE CLINICS, 2012, 28 (03) : 345 - +
  • [44] Erythropoiesis-stimulating agents in congestive heart failure patients
    Robles Perez-Monteoliva, Nicolas Roberto
    Macias Nunez, Juan Francisco
    Perez de Villar, Julio Herrera
    MEDICINA CLINICA, 2014, 142 (05): : 215 - 218
  • [45] Concerns about erythropoiesis stimulating agents in oncology: an update
    Dicato, Mario
    Plaway, Laurent
    EJHP PRACTICE, 2009, 15 (01): : 25 - 27
  • [46] Venous thromboembolic events and erythropoiesis-stimulating agents: An update
    Dicato, Mario
    ONCOLOGIST, 2008, 13 : 11 - 15
  • [47] Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
    Bohlius, Julia
    Bohlke, Kari
    Castelli, Roberto
    Djulbegovic, Benjamin
    Lustberg, Maryam B.
    Martino, Massimo
    Mountzios, Giannis
    Peswani, Namrata
    Porter, Laura
    Tanaka, Tiffany N.
    Trifiro, Gianluca
    Yang, Hushan
    Lazo-Langner, Alejandro
    BLOOD ADVANCES, 2019, 3 (08) : 1197 - 1210
  • [48] Erythropoiesis-stimulating agents in the management of cancer patients with anemia: a meta-analysis
    Xiaomei Li
    Zhi Yan
    Dexiao Kong
    Wen Zou
    Jihua Wang
    Dianshui Sun
    Yuhua Jiang
    Chengyun Zheng
    Chinese Journal of Cancer Research, 2014, 26 (03) : 268 - 276
  • [49] An Economic Evaluation of Erythropoiesis-Stimulating Agents in CKD
    Clement, Fiona M.
    Klarenbach, Scott
    Tonelli, Marcello
    Wiebe, Natasha
    Hemmelgarn, Brenda
    Manns, Braden J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (06) : 1050 - 1061
  • [50] Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia
    Inzoli, Elena
    Crisa, Elena
    Pugliese, Novella
    Civettini, Ivan
    Lanzarone, Giuseppe
    Castelli, Andrea
    Martinelli, Vincenzo
    Montelisciani, Laura
    Antolini, Laura
    Gambacorti-Passerini, Carlo
    Elli, Elena Maria
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (04) : 354 - 361
12345